Literature DB >> 23463844

Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum Beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact.

C Ho, A Lau, K Cimon, K Farrah, M Gardam.   

Abstract

Entities:  

Year:  2013        PMID： 23463844      PMCID： PMC3711525     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  41 in total

1.  Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.

Authors:  Jonas Oldgren; Marco Alings; Harald Darius; Hans-Christoph Diener; John Eikelboom; Michael D Ezekowitz; Gabriel Kamensky; Paul A Reilly; Sean Yang; Salim Yusuf; Lars Wallentin; Stuart J Connolly
Journal:  Ann Intern Med       Date:  2011-11-15       Impact factor: 25.391

2.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

3.  Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.

Authors:  Michael D Ezekowitz; Lars Wallentin; Stuart J Connolly; Amit Parekh; Michael R Chernick; Janice Pogue; Timothy H Aikens; Sean Yang; Paul A Reilly; Gregory Y H Lip; Salim Yusuf
Journal:  Circulation       Date:  2010-11-30       Impact factor: 29.690

4.  Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.

Authors:  Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Journal:  Circulation       Date:  2012-04-18       Impact factor: 29.690

Review 5.  Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.

Authors:  Geno Merli; Alex C Spyropoulos; Joseph A Caprini
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

6.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

7.  Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.

Authors:  Irina Savelieva; Abhay Bajpai; A John Camm
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 8.  Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.

Authors:  M I Aguilar; R Hart; L A Pearce
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

9.  Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.

Authors:  A L Gulløv; B G Koefoed; P Petersen; T S Pedersen; E D Andersen; J Godtfredsen; G Boysen
Journal:  Arch Intern Med       Date:  1998-07-27

10.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors:  Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321
View more
  9 in total

Review 1.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools.

Authors:  Véronique Mondain; Florence Lieutier; Céline Pulcini; Nicolas Degand; Luce Landraud; Raymond Ruimy; Thierry Fosse; Pierre Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-28       Impact factor: 3.267

3.  Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review.

Authors:  Nikos Ulrich; Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Heliyon       Date:  2017-12-28

Review 4.  More Pathogenicity or Just More Pathogens?-On the Interpretation Problem of Multiple Pathogen Detections with Diagnostic Multiplex Assays.

Authors:  Andreas E Zautner; Uwe Groß; Matthias F Emele; Ralf M Hagen; Hagen Frickmann
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

5.  Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.

Authors:  Claire L Gorrie; Mirjana Mirceta; Ryan R Wick; David J Edwards; Nicholas R Thomson; Richard A Strugnell; Nigel F Pratt; Jill S Garlick; Kerri M Watson; David V Pilcher; Steve A McGloughlin; Denis W Spelman; Adam W J Jenney; Kathryn E Holt
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

6.  Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).

Authors:  Ahmed AbdelKhalek; Nader S Abutaleb; Haroon Mohammad; Mohamed N Seleem
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

7.  Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: a systematic review and meta-analysis.

Authors:  Seyedeh Marzieh Jabbari Shiadeh; Ali Pormohammad; Ali Hashemi; Parnian Lak
Journal:  Infect Drug Resist       Date:  2019-09-02       Impact factor: 4.003

Review 8.  Patient Isolation Precautions: Are They Worth It?

Authors:  Elliott Sprague; Steven Reynolds; Peter Brindley
Journal:  Can Respir J       Date:  2016-04-12       Impact factor: 2.409

9.  Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.

Authors:  Anita Verma; Sunitha Vimalesvaran; Anil Dhawan
Journal:  Antibiotics (Basel)       Date:  2022-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.